Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
781
Inner medullary expression of the type 1<sub>A</sub> angiotensin II receptor.
Published 2015Subjects: -
782
-
783
Decreased TNIP1 expression in SSc patients.
Published 2011“…(B) Consistent with these findings, a 1.7-fold decrease of <i>TNIP1</i> mRNA levels was observed in dermal fibroblasts from SSc patients (* indicates a <i>P</i>-value = 0.001 <i>vs.…”
-
784
-
785
-
786
-
787
-
788
-
789
-
790
-
791
-
792
Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>.
Published 2015“…(p<0.05; one-way ANOVA). Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”
-
793
-
794
Image_5_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2020“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”
-
795
Image_5_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2025“…In addition, the expression of CTNNB1was decreased in the endometrium from RIF patients as well. …”
-
796
Combination metabolic therapy decreases VM-M3 cell viability <i>in vitro</i>.
Published 2015“…<p>VM-M3 cells were treated with high (control; 25mM) or low (LG; 3mM) glucose for 24 hours, with or without 5mM βHB or one session of HBOT. Viability was measured with calcein AM and Ethd-1 fluorescence microscopy. …”
-
797
-
798
Spatial stability is decreased in APP/PS1 mice in both dCA1 and vCA1.
Published 2024“…<p>(A) In dCA1, stability score was significantly decreased in APP/PS1 mice relative to C57BL/6 mice (mean ± std: C57BL/6 = -0.009 ± 0.292, APP/PS1 = -0.1845 ± 0.256, p < 10<sup>−6</sup>, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 295 units from 5 recording sessions, n<sub>APP/PS1</sub> = 167 units from 4 recording sessions). …”
-
799
-
800
Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice.
Published 2024“…Histograms show the mean firing rate for the corresponding neuron along each segment of the virtual track. (B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 305 units from 5 recording sessions, n<sub>APP/PS1</sub> = 180 units from 4 recording sessions). …”